News

A new study from researchers at the University of Sydney highlights the potential of inhalable cannabidiol (CBD) powder using ...
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeting the tumor microenvironment (TME), today announced ...
InVitria launches Optibumin® 25, the first recombinant 25% rHSA for closed-system use, enabling safer, scalable ...
Medical scientists said the breakthrough will help alleviate China's shortage of human serum albumin (HSA). HSA is a blood product vital in the treatment of a number of medical conditions ...
This morning Boots launched the No7 Future Renew Night Serum, which is claimed to be its most advanced night-time formulation yet. Boots' No7 Future Renew Night Serum has been developed through ...
Medical scientists said the breakthrough will help alleviate China's shortage of human serum albumin (HSA). HSA is a blood product vital in the treatment of a number of medical conditions, including ...